Jan Claesen

Jan Claesen

Auto-generated profile, based on publicly available information

Jan Claesen

Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute of the Cleveland Clinic

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in Cell
Verified
Journal Article
Closed access
PCPeter Cimermancic
Peter Cimermancic
MMMarnix H. Medema
Marnix H. Medema
JCJan Claesen
Jan Claesen
KKKenji Kurita
Kenji Kurita
LBLaura C. Wieland Brown
Laura C. Wieland Brown
MFMichael A. Fischbach
Michael A. Fischbach

18 August 2015 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
MMMarnix H. Medema
Marnix H. Medema
RKRenzo Kottmann
Renzo Kottmann
PYPelin Yilmaz
Pelin Yilmaz
MCMatthew Cummings
Matthew Cummings
JBJohn B Biggins
John B Biggins
FGFrank Oliver Glöckner
Frank Oliver Glöckner
A wide variety of enzymatic pathways that produce specialized metabolites in bacteria, fungi and plants are known to be encoded in biosynthetic gene clusters. Information about these clusters, pathways and metabolites is currently dispersed throughout the literature, making it difficult to exploit. To facilitate consistent and systematic deposition and retrieval of data on biosynthetic gene clusters, we propose the Minimum Information about a Biosynthetic Gene cluster (MIBiG) data standard.

15 February 2016 in Nature Reviews Microbiology
Verified
Journal Article
Open access
PDF file
MSMichael J. Smanski
Michael J. Smanski
HZHui Zhou
Hui Zhou
JCJan Claesen
Jan Claesen
BSBen Shen
Ben Shen
MFMichael A. Fischbach
Michael A. Fischbach
CVChristopher A. Voigt
Christopher A. Voigt
This Review covers the recent advances in synthetic biology and how these advances will affect the field of natural products. There has been an emphasis on creating genetic parts, such as promoters, that generate precise levels of gene expression. The generation of large libraries of well-characterized parts and the development of biophysical and bioinformatic models to predict the behaviour of genetic parts in different organisms will aid in the transfer of biosynthetic gene clusters between hosts. The capacity of DNA synthesis has exploded over the past decade and it is routine to synthesize the 20–100 kb required for a large gene cluster. In addition, new DNA assembly methods enable the rapid construction of different genetic part permutations or to substitute many genetic parts in a single step. With regard to synthetic regulation, genetic circuits have been constructed that function as logic gates, timers, switches and oscillators. Sensors have also been developed that respond to many inducible inputs as well as metabolite levels. These could be incorporated into natural product pathways to control the timing of expression of different genes or to implement feedback in response to a toxic intermediate. It is often desirable to make many simultaneous genomic changes. Methods such as CRISPR–Cas9 can target essentially any region of the genome and have been shown to function in many species, including several host species that are well suited for the industrial-scale production of small molecules.

23 March 2010 in PLOS Biology
Verified
Journal Article
Open access
PDF file
YGYuki Goto
Yuki Goto
BLBo Li
Bo Li
JCJan Claesen
Jan Claesen
YSYanxiang Shi
Yanxiang Shi
MBMervyn J. Bibb
Mervyn J. Bibb
WDWilfred A. Van Der Donk
Wilfred A. Van Der Donk
Lantibiotic synthetases are remarkable biocatalysts generating conformationally constrained peptides with a variety of biological activities by repeatedly utilizing two simple posttranslational modification reactions: dehydration of Ser/Thr residues and intramolecular addition of Cys thiols to the resulting dehydro amino acids. Since previously reported lantibiotic synthetases show no apparent homology with any other known protein families, the molecular mechanisms and evolutionary origin of these enzymes are unknown. In this study, we present a novel class of lanthionine synthetases, termed LanL, that consist of three distinct catalytic domains and demonstrate in vitro enzyme activity of a family member from Streptomyces venezuelae. Analysis of individually expressed and purified domains shows that LanL enzymes install dehydroamino acids via phosphorylation of Ser/Thr residues by a protein kinase domain and subsequent elimination of the phosphate by a phosphoSer/Thr lyase domain. The latter has sequence homology with the phosphothreonine lyases found in various pathogenic bacteria that inactivate host mitogen activated protein kinases. A LanC-like cyclase domain then catalyzes the addition of Cys residues to the dehydro amino acids to form the characteristic thioether rings. We propose that LanL enzymes have evolved from stand-alone protein Ser/Thr kinases, phosphoSer/Thr lyases, and enzymes catalyzing thiol alkylation. We also demonstrate that the genes for all three pathways to lanthionine-containing peptides are widespread in Nature. Given the remarkable efficiency of formation of lanthionine-containing polycyclic peptides and the latter's high degree of specificity for their cognate cellular targets, it is perhaps not surprising that (at least) three distinct families of polypeptide sequences have evolved to access this structurally and functionally diverse class of compounds. Many bacteria generate cyclic peptides, which have improved biological activities compared to linear peptides, including higher stability. Lanthionine-containing peptides are one such group, and different members of this group have antibiotic, anti-inflammatory, and anti-viral activities. For example, one lanthionine-containing peptide called nisin has been used to protect food items from harmful bacteria. Two different pathways for the biosynthesis of lanthionine-containing peptides have been described previously. By comparing the DNA sequences of bacterial genomes we reveal a third biosynthetic route that provides further insight into how the biosynthetic pathways for these cyclic peptides have evolved. We characterized the novel lanthionine synthetase utilized in this third pathway in the soil bacterium Streptomyces venezuelae and show that the purified enzyme catalyzes the chemical reactions necessary to turn a linear peptide into a peptide with multiple rings. The discovery of this third biosynthetic pathway widens the scope for the engineering of new lanthionine-containing peptides for potential use in human therapeutics.

30 January 2018 in Journal of Experimental Medicine
Verified
Journal Article
Open access
VRVanessa K. Ridaura
Vanessa K. Ridaura
NBNicolas Bouladoux
Nicolas Bouladoux
JCJan Claesen
Jan Claesen
YCY. Erin Chen
Y. Erin Chen
ABAllyson L. Byrd
Allyson L. Byrd
YBYasmine Belkaid
Yasmine Belkaid
How defined microbes influence the skin immune system remains poorly understood. Here we demonstrate that Corynebacteria, dominant members of the skin microbiota, promote a dramatic increase in the number and activation of a defined subset of γδ T cells. This effect is long-lasting, occurs independently of other microbes, and is, in part, mediated by interleukin (IL)-23. Under steady-state conditions, the impact of Corynebacterium is discrete and noninflammatory. However, when applied to the skin of a host fed a high-fat diet, Corynebacterium accolens alone promotes inflammation in an IL-23–dependent manner. Such effect is highly conserved among species of Corynebacterium and dependent on the expression of a dominant component of the cell envelope, mycolic acid. Our data uncover a mode of communication between the immune system and a dominant genus of the skin microbiota and reveal that the functional impact of canonical skin microbial determinants is contextually controlled by the inflammatory and metabolic state of the host.

18 November 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
JCJan Claesen
Jan Claesen
JSJennifer B. Spagnolo
Jennifer B. Spagnolo
SRStephany Flores Ramos
Stephany Flores Ramos
KKKenji L. Kurita
Kenji L. Kurita
ABAllyson L. Byrd
Allyson L. Byrd
KLKatherine P. Lemon
Katherine P. Lemon
Cutimycin, a thiopeptide antibiotic produced by the skin commensal Cutibacterium acnes , reduces Staphylococcus colonization of human skin hair follicles.